purchase customization

1 Study Coverage
1.1 RNA-based Biopharmaceuticals Product Introduction
1.2 Market by Type
1.2.1 Global RNA-based Biopharmaceuticals Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Therapeutics
1.2.3 Vaccines
1.3 Market by Application
1.3.1 Global RNA-based Biopharmaceuticals Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Cancer
1.3.3 Diabetes
1.3.4 Tuberculosis
1.3.5 Cardiovascular Diseases
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global RNA-based Biopharmaceuticals Sales Estimates and Forecasts 2017-2028
2.2 Global RNA-based Biopharmaceuticals Revenue Estimates and Forecasts 2017-2028
2.3 Global RNA-based Biopharmaceuticals Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global RNA-based Biopharmaceuticals Sales by Region
2.4.1 Global RNA-based Biopharmaceuticals Sales by Region (2017-2022)
2.4.2 Global Sales RNA-based Biopharmaceuticals by Region (2023-2028)
2.5 Global RNA-based Biopharmaceuticals Revenue by Region
2.5.1 Global RNA-based Biopharmaceuticals Revenue by Region (2017-2022)
2.5.2 Global RNA-based Biopharmaceuticals Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global RNA-based Biopharmaceuticals Sales by Manufacturers
3.1.1 Global Top RNA-based Biopharmaceuticals Manufacturers by Sales (2017-2022)
3.1.2 Global RNA-based Biopharmaceuticals Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of RNA-based Biopharmaceuticals in 2021
3.2 Global RNA-based Biopharmaceuticals Revenue by Manufacturers
3.2.1 Global RNA-based Biopharmaceuticals Revenue by Manufacturers (2017-2022)
3.2.2 Global RNA-based Biopharmaceuticals Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by RNA-based Biopharmaceuticals Revenue in 2021
3.3 Global RNA-based Biopharmaceuticals Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global RNA-based Biopharmaceuticals Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global RNA-based Biopharmaceuticals Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global RNA-based Biopharmaceuticals Sales by Type
4.1.1 Global RNA-based Biopharmaceuticals Historical Sales by Type (2017-2022)
4.1.2 Global RNA-based Biopharmaceuticals Forecasted Sales by Type (2023-2028)
4.1.3 Global RNA-based Biopharmaceuticals Sales Market Share by Type (2017-2028)
4.2 Global RNA-based Biopharmaceuticals Revenue by Type
4.2.1 Global RNA-based Biopharmaceuticals Historical Revenue by Type (2017-2022)
4.2.2 Global RNA-based Biopharmaceuticals Forecasted Revenue by Type (2023-2028)
4.2.3 Global RNA-based Biopharmaceuticals Revenue Market Share by Type (2017-2028)
4.3 Global RNA-based Biopharmaceuticals Price by Type
4.3.1 Global RNA-based Biopharmaceuticals Price by Type (2017-2022)
4.3.2 Global RNA-based Biopharmaceuticals Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global RNA-based Biopharmaceuticals Sales by Application
5.1.1 Global RNA-based Biopharmaceuticals Historical Sales by Application (2017-2022)
5.1.2 Global RNA-based Biopharmaceuticals Forecasted Sales by Application (2023-2028)
5.1.3 Global RNA-based Biopharmaceuticals Sales Market Share by Application (2017-2028)
5.2 Global RNA-based Biopharmaceuticals Revenue by Application
5.2.1 Global RNA-based Biopharmaceuticals Historical Revenue by Application (2017-2022)
5.2.2 Global RNA-based Biopharmaceuticals Forecasted Revenue by Application (2023-2028)
5.2.3 Global RNA-based Biopharmaceuticals Revenue Market Share by Application (2017-2028)
5.3 Global RNA-based Biopharmaceuticals Price by Application
5.3.1 Global RNA-based Biopharmaceuticals Price by Application (2017-2022)
5.3.2 Global RNA-based Biopharmaceuticals Price Forecast by Application (2023-2028)
6 North America
6.1 North America RNA-based Biopharmaceuticals Market Size by Type
6.1.1 North America RNA-based Biopharmaceuticals Sales by Type (2017-2028)
6.1.2 North America RNA-based Biopharmaceuticals Revenue by Type (2017-2028)
6.2 North America RNA-based Biopharmaceuticals Market Size by Application
6.2.1 North America RNA-based Biopharmaceuticals Sales by Application (2017-2028)
6.2.2 North America RNA-based Biopharmaceuticals Revenue by Application (2017-2028)
6.3 North America RNA-based Biopharmaceuticals Market Size by Country
6.3.1 North America RNA-based Biopharmaceuticals Sales by Country (2017-2028)
6.3.2 North America RNA-based Biopharmaceuticals Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe RNA-based Biopharmaceuticals Market Size by Type
7.1.1 Europe RNA-based Biopharmaceuticals Sales by Type (2017-2028)
7.1.2 Europe RNA-based Biopharmaceuticals Revenue by Type (2017-2028)
7.2 Europe RNA-based Biopharmaceuticals Market Size by Application
7.2.1 Europe RNA-based Biopharmaceuticals Sales by Application (2017-2028)
7.2.2 Europe RNA-based Biopharmaceuticals Revenue by Application (2017-2028)
7.3 Europe RNA-based Biopharmaceuticals Market Size by Country
7.3.1 Europe RNA-based Biopharmaceuticals Sales by Country (2017-2028)
7.3.2 Europe RNA-based Biopharmaceuticals Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific RNA-based Biopharmaceuticals Market Size by Type
8.1.1 Asia Pacific RNA-based Biopharmaceuticals Sales by Type (2017-2028)
8.1.2 Asia Pacific RNA-based Biopharmaceuticals Revenue by Type (2017-2028)
8.2 Asia Pacific RNA-based Biopharmaceuticals Market Size by Application
8.2.1 Asia Pacific RNA-based Biopharmaceuticals Sales by Application (2017-2028)
8.2.2 Asia Pacific RNA-based Biopharmaceuticals Revenue by Application (2017-2028)
8.3 Asia Pacific RNA-based Biopharmaceuticals Market Size by Region
8.3.1 Asia Pacific RNA-based Biopharmaceuticals Sales by Region (2017-2028)
8.3.2 Asia Pacific RNA-based Biopharmaceuticals Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America RNA-based Biopharmaceuticals Market Size by Type
9.1.1 Latin America RNA-based Biopharmaceuticals Sales by Type (2017-2028)
9.1.2 Latin America RNA-based Biopharmaceuticals Revenue by Type (2017-2028)
9.2 Latin America RNA-based Biopharmaceuticals Market Size by Application
9.2.1 Latin America RNA-based Biopharmaceuticals Sales by Application (2017-2028)
9.2.2 Latin America RNA-based Biopharmaceuticals Revenue by Application (2017-2028)
9.3 Latin America RNA-based Biopharmaceuticals Market Size by Country
9.3.1 Latin America RNA-based Biopharmaceuticals Sales by Country (2017-2028)
9.3.2 Latin America RNA-based Biopharmaceuticals Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa RNA-based Biopharmaceuticals Market Size by Type
10.1.1 Middle East and Africa RNA-based Biopharmaceuticals Sales by Type (2017-2028)
10.1.2 Middle East and Africa RNA-based Biopharmaceuticals Revenue by Type (2017-2028)
10.2 Middle East and Africa RNA-based Biopharmaceuticals Market Size by Application
10.2.1 Middle East and Africa RNA-based Biopharmaceuticals Sales by Application (2017-2028)
10.2.2 Middle East and Africa RNA-based Biopharmaceuticals Revenue by Application (2017-2028)
10.3 Middle East and Africa RNA-based Biopharmaceuticals Market Size by Country
10.3.1 Middle East and Africa RNA-based Biopharmaceuticals Sales by Country (2017-2028)
10.3.2 Middle East and Africa RNA-based Biopharmaceuticals Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Corporation Information
11.1.2 Pfizer Overview
11.1.3 Pfizer RNA-based Biopharmaceuticals Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Pfizer RNA-based Biopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Pfizer Recent Developments
11.2 Roche
11.2.1 Roche Corporation Information
11.2.2 Roche Overview
11.2.3 Roche RNA-based Biopharmaceuticals Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Roche RNA-based Biopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Roche Recent Developments
11.3 Sanofi-Aventis
11.3.1 Sanofi-Aventis Corporation Information
11.3.2 Sanofi-Aventis Overview
11.3.3 Sanofi-Aventis RNA-based Biopharmaceuticals Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Sanofi-Aventis RNA-based Biopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Sanofi-Aventis Recent Developments
11.4 Abbott Laboratories
11.4.1 Abbott Laboratories Corporation Information
11.4.2 Abbott Laboratories Overview
11.4.3 Abbott Laboratories RNA-based Biopharmaceuticals Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Abbott Laboratories RNA-based Biopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Abbott Laboratories Recent Developments
11.5 Arrowhead Pharmaceuticals
11.5.1 Arrowhead Pharmaceuticals Corporation Information
11.5.2 Arrowhead Pharmaceuticals Overview
11.5.3 Arrowhead Pharmaceuticals RNA-based Biopharmaceuticals Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Arrowhead Pharmaceuticals RNA-based Biopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Arrowhead Pharmaceuticals Recent Developments
11.6 Benitec Biopharma
11.6.1 Benitec Biopharma Corporation Information
11.6.2 Benitec Biopharma Overview
11.6.3 Benitec Biopharma RNA-based Biopharmaceuticals Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Benitec Biopharma RNA-based Biopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Benitec Biopharma Recent Developments
11.7 Calimmune Inc
11.7.1 Calimmune Inc Corporation Information
11.7.2 Calimmune Inc Overview
11.7.3 Calimmune Inc RNA-based Biopharmaceuticals Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Calimmune Inc RNA-based Biopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Calimmune Inc Recent Developments
11.8 Dicerna
11.8.1 Dicerna Corporation Information
11.8.2 Dicerna Overview
11.8.3 Dicerna RNA-based Biopharmaceuticals Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Dicerna RNA-based Biopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Dicerna Recent Developments
11.9 Gradalis
11.9.1 Gradalis Corporation Information
11.9.2 Gradalis Overview
11.9.3 Gradalis RNA-based Biopharmaceuticals Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Gradalis RNA-based Biopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Gradalis Recent Developments
11.10 Quark
11.10.1 Quark Corporation Information
11.10.2 Quark Overview
11.10.3 Quark RNA-based Biopharmaceuticals Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Quark RNA-based Biopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Quark Recent Developments
11.11 RXi
11.11.1 RXi Corporation Information
11.11.2 RXi Overview
11.11.3 RXi RNA-based Biopharmaceuticals Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 RXi RNA-based Biopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 RXi Recent Developments
11.12 Senesco
11.12.1 Senesco Corporation Information
11.12.2 Senesco Overview
11.12.3 Senesco RNA-based Biopharmaceuticals Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Senesco RNA-based Biopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Senesco Recent Developments
11.13 Silence Therapeutics
11.13.1 Silence Therapeutics Corporation Information
11.13.2 Silence Therapeutics Overview
11.13.3 Silence Therapeutics RNA-based Biopharmaceuticals Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Silence Therapeutics RNA-based Biopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Silence Therapeutics Recent Developments
11.14 Silenseed
11.14.1 Silenseed Corporation Information
11.14.2 Silenseed Overview
11.14.3 Silenseed RNA-based Biopharmaceuticals Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Silenseed RNA-based Biopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Silenseed Recent Developments
11.15 Tekmira
11.15.1 Tekmira Corporation Information
11.15.2 Tekmira Overview
11.15.3 Tekmira RNA-based Biopharmaceuticals Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Tekmira RNA-based Biopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Tekmira Recent Developments
11.16 Alnylam Pharmaceuticals
11.16.1 Alnylam Pharmaceuticals Corporation Information
11.16.2 Alnylam Pharmaceuticals Overview
11.16.3 Alnylam Pharmaceuticals RNA-based Biopharmaceuticals Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 Alnylam Pharmaceuticals RNA-based Biopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Alnylam Pharmaceuticals Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 RNA-based Biopharmaceuticals Industry Chain Analysis
12.2 RNA-based Biopharmaceuticals Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 RNA-based Biopharmaceuticals Production Mode & Process
12.4 RNA-based Biopharmaceuticals Sales and Marketing
12.4.1 RNA-based Biopharmaceuticals Sales Channels
12.4.2 RNA-based Biopharmaceuticals Distributors
12.5 RNA-based Biopharmaceuticals Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 RNA-based Biopharmaceuticals Industry Trends
13.2 RNA-based Biopharmaceuticals Market Drivers
13.3 RNA-based Biopharmaceuticals Market Challenges
13.4 RNA-based Biopharmaceuticals Market Restraints
14 Key Findings in The Global RNA-based Biopharmaceuticals Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer